ASTHALIN

Dosage : Inhaler
Contains : Salbutamol
Category : β2-adrenergic receptor agonist
Uses : bronchospasm, asthma, chronic obstructive pulmonary disease
Price :

Asthalin is an anti-asthmatic in the form of inhaler. Asthalin is widely used as a bronchodilator to manage asthma and other chronic obstructive airway diseases and also used for chronic bronchitis, and other chronic bronchopulmonary disorders such as COPD.

 

Asthalin is contains Salbutamol sulphate which is usually given by the inhaled route for direct effect on bronchial smooth muscle. Salbutamol is a short acting β2-adrenergic receptor agonist (SABA) treats constriction of the lung airways and helps in dilation thereby making breathing easier.This is usually achieved through a metered dose inhaler (MDI), nebuliser or other proprietary delivery devices (e.g. Rotahaler or Autohaler). Salbutamol can also be given orally as an inhalant or intravenously.

 

Asthalin is a product of Cipla limited which is an Indian multinational pharmaceutical and biotechnology company. It is primarily into development of medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control, depression and other medical conditions. The company’s goal is ensuring that no patient shall be denied access to high quality and affordable medicines and support with the vision to make India self-sufficient in health care.

 

Your doctor may have prescribed Asthalin because you could be suffering from Wheezing and Shortness of Breath due to Breathing Problems.

 

Asthalin is an orally available medication that contains the active substance Salbutamol also known as Albuterol. It is a bronchodilator which works by relaxing muscles and opening airway passages to the lungs in order to improve breathing.

 

Wheezing and shortness of breath can occur due to tightness or pressure in the chest which may result when the lungs can’t hold as much air when they are affected by swelling or mucus buildup. It can be caused by asthma or chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema.

 

Patients suffering from wheezing and shortness of breath should prevent symptoms such as weakness, weight loss, nausea, muscle pain, headache, tiredness and dizziness. Salbutamol can be used to treat lung disorders that may include:

 

  • Acute Asthma
  • Asthma maintenance
  • Chronic obstructive pulmonary disease
  • Bronchitis
  • Uncomplicated preterm labor

 

Asthalin syrup has been known to work well among patients with lung disorders.

 

 

Dosage

As directed by your physician

Administration

As directed by your physician

Adverse Reactions/ Side Effects

Tremor, nervousness, nausea and vomiting, tachycardia, palpitations, chest pain, shakiness, dizziness, headache, insomnia, inhalation site sensation, hyperactivity, HTN, hypotension, increased sweating, allergic reactions, DM, muscle cramps, flu-like syndrome, conjunctivitis, UTI, hypokalaemia,. Rarely, erythema multiforme, Stevens-Johnson syndrome.

Potentially Fatal: Paradoxical bronchospasm.

Warnings and Precautions

Hyperthyroidism, myocardial insufficiency, arrhythmias, susceptibility to QT-interval prolongation, HTN, DM, glaucoma, hypokalaemia, seizure disorder. Renal impairment. Elderly. Pregnancy and lactation. Monitoring Parameters Monitor BP, heart rate, electrolyte and fluid balance; glucose, lactate and K levels

Contraindications

IV (in the treatment of premature labour): Pre-existing or risk factors for ischaemic heart disease, gestational age <22 wk, conditions in which prolongation of pregnancy is hazardous (e.g. severe toxaemia, intrauterine infection, vag bleeding resulting from placenta praevia, eclampsia or severe preeclampsia, placental abruption, cord compression; use in threatened abortion.

 

Drug Interactions

Increased risk of hypokalemia w/ K depleting agents (e.g. corticosteroid, diuretics, xanthines, digoxin). Increased uterine inertia w/ halogenated anaesth (IV). Increased risk of pulmonary oedema w/ corticosteroids. May antagonise the effect of anti-diabetics. Effects may be altered by guanethidine, reserpine, methyldopa, TCAs and MAOIs. Increased risk of CV effects w/ other sympathomimetic agents. Antagonistic effect w/ β-blockers.

Overdosage

Symptoms: Tachycardia, CNS stimulation, tremor, hypokalaemia, hyperglycaemia, lactic acidosis, nausea, vomiting. Management: Symptomatic and supportive treatment. May administer activated charcoal. β-blocking agents (e.g. metoprolol) may be given but w/ extreme caution in asthmatic patients.

 

Storage

Inhalation: Store between 15-30°C. Protect from light. Intravenous: Store between 15-30°C. Protect from light. Oral: Store between 15-30°C. Protect from light. Parenteral: Store between 15-30°C. Protect from light.

Mechanism of Action

–

References

https://www.drugs.com/international/salbutamol.html

https://www.merckvetmanual.com/pharmacology/systemic-pharmacotherapeutics-of-the-respiratory-system/inhalation-therapy-of-airway-disease

https://www.cipla.com/

If you are a healthcare practitioner and want additional material on the brand, disease, or molecule we have a few articles that can be hand-delivered by the company representative to you directly.

MEDIA

NEED FURTHER INFO?